TD Ameritrade Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,122
| Closed | -$438K | – | 38 |
|
|
2023
Q2 | $438K | Sell |
6,122
-1,447
| -19% | -$104K | ﹤0.01% | 123 |
|
|
2023
Q1 | $525K | Sell |
7,569
-1,042
| -12% | -$72.3K | 0.01% | 122 |
|
|
2022
Q4 | $584K | Sell |
8,611
-2,817
| -25% | -$191K | 0.01% | 125 |
|
|
2022
Q3 | $627K | Sell |
11,428
-2,134
| -16% | -$117K | 0.01% | 130 |
|
|
2022
Q2 | $896K | Sell |
13,562
-3,408
| -20% | -$225K | 0.01% | 128 |
|
|
2022
Q1 | $1.13M | Buy |
16,970
+292
| +2% | +$19.4K | 0.01% | 126 |
|
|
2021
Q4 | $971K | Buy |
16,678
+11,956
| +253% | +$696K | 0.01% | 129 |
|
|
2021
Q3 | $259K | Sell |
4,722
-1,726
| -27% | -$94.7K | ﹤0.01% | 198 |
|
|
2021
Q2 | $386K | Buy |
6,448
+1,546
| +32% | +$92.5K | ﹤0.01% | 185 |
|
|
2021
Q1 | $245K | Hold |
4,902
| – | – | ﹤0.01% | 207 |
|
|
2020
Q4 | $245K | Buy |
4,902
+180
| +4% | +$9K | ﹤0.01% | 207 |
|
|
2020
Q3 | $259K | Sell |
4,722
-26
| -0.5% | -$1.43K | ﹤0.01% | 198 |
|
|
2020
Q2 | $251K | Buy |
4,748
+88
| +2% | +$4.65K | ﹤0.01% | 198 |
|
|
2020
Q1 | $208K | Sell |
4,660
-743
| -14% | -$33.2K | ﹤0.01% | 196 |
|
|
2019
Q4 | $269K | Buy |
5,403
+1,783
| +49% | +$88.8K | ﹤0.01% | 189 |
|
|
2019
Q3 | $161K | Buy |
3,620
+2,004
| +124% | +$89.1K | ﹤0.01% | 192 |
|
|
2019
Q2 | $67K | Buy |
1,616
+799
| +98% | +$33.1K | ﹤0.01% | 228 |
|
|
2019
Q1 | $33K | Sell |
817
-64
| -7% | -$2.59K | ﹤0.01% | 275 |
|
|
2018
Q4 | $33K | Sell |
881
-83
| -9% | -$3.11K | ﹤0.01% | 262 |
|
|
2018
Q3 | $38K | Buy |
964
+903
| +1,480% | +$35.6K | ﹤0.01% | 230 |
|
|
2018
Q2 | $2K | Buy |
+61
| New | +$2K | ﹤0.01% | 330 |
|